Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease)
Developmental Neurobiology · 2023
DOI: 10.1002/dneu.22918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Neurobiology, 2023. Verfasst von Nadia L Mitchell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Agriculture and Life Sciences, Lincoln University, Lincoln, New Zealand. Hauptthemen laut MEDLINE: Neuronal Ceroid-Lipofuscinoses. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Batten Disease Support and Research Association.
Abstract (Originalsprache)
Sheep with naturally occurring CLN5 and CLN6 forms of neuronal ceroid lipofuscinoses (Batten disease) share the key clinical features of the human disease and represent an ideal model system in which the clinical efficacy of gene therapies is developed and test. However, it was first important to characterize the neuropathological changes that occur with disease progression in affected sheep. This study compared neurodegeneration, neuroinflammation, and lysosomal storage accumulation in CLN5 affected Borderdale, CLN6 affected South Hampshire, and Merino sheep brains from birth to end‐stage disease at ≤24 months of age. Despite very different gene products, mutations, and subcellular localizations, the pathogenic cascade was remarkably similar for all three disease models. Glial activation was present at birth in affected sheep and preceded neuronal loss, with both spreading from the visual and parieto‐occipital cortices most prominently associated with clinical symptoms to the entire cortical mantle by end‐stage disease. In contrast, the subcortical regions were less involved, yet lysosomal storage followed a near‐linear increase across the diseased sheep brain with age. Correlation of these neuropathological changes with published clinical data identified three potential therapeutic windows in affected sheep—presymptomatic (3 months), early symptomatic (6 months), and a later symptomatic disease stage (9 months of age)—beyond which the extensive depletion of neurons was likely to diminish any chance of therapeutic benefit. This comprehensive natural history of the neuropathological changes in ovine CLN5 and CLN6 disease will be integral in determining what impact treatment has at each of these disease stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Agriculture and Life Sciences, Lincoln University, Lincoln, New Zealand.
- Faculty of Science, Sydney School of Veterinary Science, The University of Sydney, Camperdown, New South Wales, Australia.
ORCID-Profile: Nadia L Mitchell, Graham K Barrell, Imke Tammen, David N Palmer
Förderung
- Batten Disease Support and Research Association
Zitieren
APA
Mitchell, N. L., Russell, K. N., Barrell, G. K., Tammen, I., & Palmer, D. N. (2023). Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease). Developmental Neurobiology. https://doi.org/10.1002/dneu.22918
Vancouver
Mitchell NL, Russell KN, Barrell GK, Tammen I, Palmer DN. Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease). Developmental Neurobiology. 2023. doi:10.1002/dneu.22918
BibTeX
@article{Mitchell2023,
author = {Mitchell, Nadia L and Russell, Katharina N and Barrell, Graham K and Tammen, Imke and Palmer, David N},
title = {Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease)},
journal = {Developmental Neurobiology},
year = {2023},
doi = {10.1002/dneu.22918}
}
EUVIMED